Y. Chi, and C. Chen. Statistics in medicine, 27 (29):
6175-89(December 2008)5263<m:linebreak></m:linebreak>LR: 20090730; JID: 8215016; 0 (Antineoplastic Agents); 33419-42-0 (Etoposide); ppublish;<m:linebreak></m:linebreak>Fase II.
W. Sauerbrei, P. Royston, and H. Binder. Statistics in medicine, 26 (30):
5512-28(December 2007)4592<m:linebreak></m:linebreak>CI: Copyright (c) 2007; JID: 8215016; 0 (Antineoplastic Agents); ppublish;<m:linebreak></m:linebreak>Anàlisi de dades.
R. Tuma. Journal of the National Cancer Institute, 101 (21):
1439-41(November 2009)5434<m:linebreak></m:linebreak>JID: 7503089; 0 (Antineoplastic Agents); 2009/10/14 aheadofprint; ppublish;<m:linebreak></m:linebreak>Anàlisi de supervivència.
G. Apolone. Health and quality of life outcomes, (January 2003)5220<m:linebreak></m:linebreak>JID: 101153626; 0 (Antineoplastic Agents); OID: NLM: PMC155672; 2003/02/27 received; 2003/04/03 accepted; 2003/04/03 aheadofprint; epublish;<m:linebreak></m:linebreak>Mesures de resultats.